Financial Ratios

SAKAR HEALTHCARE LTD.

NSE : SAKARBSE : ISIN CODE : INE732S01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE358.35-2.85 (-0.79 %)
PREV CLOSE( ) 361.20
OPEN PRICE ( ) 369.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 358.35 (1)
VOLUME 11350
TODAY'S LOW / HIGH( ) 354.00 369.00
52 WK LOW / HIGH ( )210 479
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)6.708.906.856.434.47
   CEPS(Rs)14.5714.5512.0111.168.51
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)91.0974.5063.0454.3547.95
   Tax Rate(%)24.9119.8119.2621.3027.52
Margin Ratios
   Core EBITDA Margin(%)24.9522.9423.8823.5624.71
   EBIT Margin(%)17.2117.0916.6117.4616.86
   Pre Tax Margin(%)12.7414.8213.9814.7313.53
   PAT Margin (%)9.5711.8911.2911.609.81
   Cash Profit Margin (%)20.8019.4319.7920.1318.66
Performance Ratios
   ROA(%)4.226.847.309.067.50
   ROE(%)8.4813.4911.8912.5711.29
   ROCE(%)8.9512.1313.1616.0215.45
   Asset Turnover(x)0.440.580.650.780.76
   Sales/Fixed Asset(x)0.490.791.121.120.93
   Working Capital/Sales(x)88.9638.58179.0211.1911.06
Efficiency Ratios
   Fixed Capital/Sales(x)2.031.270.890.891.07
   Receivable days49.6237.8039.7039.0154.34
   Inventory Days40.4842.5351.3039.1328.85
   Payable days140.43123.3090.0539.9843.28
Valuation Parameters
   PER(x)29.9415.1816.527.7711.04
   PCE(x)13.779.299.424.475.80
   Price/Book(x)2.201.811.790.921.03
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)3.762.532.311.101.24
   EV/Core EBITDA(x)13.2010.269.214.234.83
   EV/EBIT(x)21.8314.7913.936.297.36
   EV/CE(x)1.491.211.230.790.87
   M Cap / Sales2.861.801.860.901.08
Growth Ratio
   Net Sales Growth(%)4.0035.3514.1721.5828.59
   Core EBITDA Growth(%)20.1332.7410.3422.9233.87
   EBIT Growth(%)4.7339.288.6425.9132.29
   PAT Growth(%)-16.3042.5611.1143.7875.45
   EPS Growth(%)-24.7530.076.4443.7843.20
Financial Stability Ratios
   Total Debt/Equity(x)0.690.730.430.210.16
   Current Ratio(x)1.031.071.021.521.44
   Quick Ratio(x)0.740.770.540.750.95
   Interest Cover(x)3.857.536.316.415.07
   Total Debt/Mcap(x)0.310.400.240.220.15

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.